Ubs Group Ag Agilent Technologies, Inc. Call Options Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	BUY	$128.12 - $149.31 $704,660 - $821,205	5,500 New	5,500 $800,000
Q4 2021 Feb 14, 2022	BUY	$147.95 - $164.3 $2.96 Million - $3.29 Million	20,000 Added 133.33%	35,000 $5.59 Million
Q1 2021 May 12, 2021	SELL	$114.99 - $130.12 $2.39 Million - $2.71 Million	-20,800 Reduced 58.1%	15,000 $1.91 Million
Q4 2019 Feb 14, 2020	BUY	$72.49 - $85.45 $1.81 Million - $2.14 Million	25,000 Added 231.48%	35,800 $3.05 Million
Q4 2018 Feb 14, 2019	SELL	$61.13 - $74.67 $635,752 - $776,568	-10,400 Reduced 49.06%	10,800 $729,000
Q3 2018 Nov 14, 2018	BUY	$61.25 - $71.13 $263,375 - $305,859	4,300 Added 25.44%	21,200 $1.5 Million
Q1 2018 May 15, 2018	SELL	$65.05 - $74.82 $858,660 - $987,623	-13,200 Reduced 43.85%	16,900 $1.13 Million
Q4 2017 Feb 14, 2018	BUY	$64.87 - $70.59 $1.66 Million - $1.81 Million	25,600 Added 568.89%	30,100 $2.02 Million
Q1 2017 Nov 14, 2017	BUY	N/A	4,500	4,500 $238,000

1,148

252M

729K

970K

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $39.6B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.